The annual meeting of EASD the European Association for the Study of Diabetes is being held in Berlin this week. This is a chance for researchers to showcase the latest diabetes research including the latest and most advanced continuous glucose monitoring (CGM) technology.
Senseonics Inc. have a poster at the event detailing their latest research into an implantable glucose sensor. They have developed a tiny chip about 3mm in length that can be implanted under the skin in the arm. When the chip comes in contact with glucose, it sends a fluorescent signal to a ‘reader’ that is worn as an armband. The implantable sensor is designed to work for six months.
The armband reader can then send the glucose readings to a smartphone app the team have developed or the readings can be downloaded to a computer. The app also allows the user to enter data on what they have eaten or how much insulin they have taken.
The team have just completed a small pilot study with of their new technology with only 12 participants so must now run a larger trial to test how well it works among a larger group of people before it can be approved for sale.
Dexcom are also presenting the results of a trial of their latest CGM G4 Platinum this week. In this trial they compared their new system to their current product Dexcom SEVEN PLUS.
The G4 Platinum sensor was shown to be more accurate than the SEVEN PLUS, had less variability between individual sensors and had fewer interupptions in the CGM readings. However, the study does not compare the G4 Platinum to any other CGM on the market.